tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Schwartz, 45 are a HOLD (18.75%), 189 are a BUY (78.75%), 6 are a SELL (2.5%).
Analyst Joseph Schwartz works at LEERINK with a stock forecast success ratio of 51.88% fulfilled within 280.59 days on average.
Joseph Schwartz’s has documented 481 price targets and ratings displayed on 44 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ANTX, AN2 Therapeutics at 13-Feb-2024.
Analyst best performing recommendations are on LRMR (LARIMAR THERAPEUTICS).
The best stock recommendation documented was for LRMR (LARIMAR THERAPEUTICS) at 12/1/2015. The price target of $132 was fulfilled within 1 day with a profit of $59.16 (30.95%) receiving and performance score of 309.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
13.75
14
3 years 6 months 24 days ago
13/18 (72.22%)
$0.67 (5.12%)
50
Buy
13.75
14
3 years 6 months 27 days ago
5/7 (71.43%)
$0.01 (0.07%)
130
Hold
10
$-3.75 (-27.27%)
13
3 years 8 months 11 days ago
6/8 (75%)
$-0.63 (-5.93%)
126
Buy
10
$-3.75 (-27.27%)
14
3 years 8 months 11 days ago
1/5 (20%)
$-0.63 (-5.93%)
6
Hold
3 years 8 months 22 days ago
0/3 (0%)
$17.19 (61.81%)
Which stock is Joseph Schwartz is most bullish on?
Which stock is Joseph Schwartz is most reserved on?
What Year was the first public recommendation made by Joseph Schwartz?
